Key Summary
- NICE appoints Dr Adrian Hayter as CMO.
- He is a health expert with over 30 years of leadership expertise.
- Expected to drive person-centred care and faster access to treatments.
The National Institute for Health and Care Excellence (NICE) appointed Dr Adrian Hayter as its new chief medical officer (CMO), following the appointment of Dr Jonathan Benger as this year’s CEO.
He has thirty years of frontline clinical and national leadership experience including general practice, NHS commissioning and national clinical leadership, which are key for his new position.
His leadership roles consist of chairing the Windsor, Ascot and Maidenhead Clinical Commissioning Group from 2013 to 2018, the first GP to become the National Clinical director for Older People and Person-Centred Care by NHS England, a role he held throughout the Covid-19 pandemic.
Dr Hayter also serves as a visiting Professor of Gerontology at Singapore University of Social Science, while also contributes to the Royal College of General Practitioners (RCGP) as its medical director for Clinical Policy.
He is a practicing GP and GP partner at Runnymede Medical Practice, known for his dedication towards primary care.
Dr Hayter’s wide range of experience is expected to help the NHS’s shift to neighbourhood-based, person-centred care through his leadership at NICE.
NICE is all set to expand its technology appraisal process which requires funding from the NHS, and a new joint process with the MHRA for improved patient access to medicines upto six months, by this month.
With such expert guidance, NICE will constantly review and improve its clinical pathways to improve the healthcare system.
“I am delighted to welcome Adrian to NICE as our new chief medical officer,” said Professor Jonathan Benger, chief executive at NICE.
“Adrian's ability to forge and sustain those relationships will be invaluable as we work together to get the best evidence-based care to patients fast, while ensuring value for the taxpayer,” he added.
Regarding his appointment, Hayter said, “I am honoured to be joining NICE as chief medical officer at such a critical time for health and care. As a GP, I rely on NICE guidance every day to make sure my patients receive the best evidence-based care, from prescribing decisions to managing long-term conditions.”
“"I know first-hand how vital it is that NICE's guidance is not only independent, but developed in a way that allows clinicians to deliver the best possible care, and I am committed to ensuring NICE continues to play its full part in a health system that must keep evolving to meet the needs of patients and the public,” he added.
